What Is Haemangioendothelioma of the Liver?
Haemangioendothelioma of the liver is a rare vascular tumour that arises from the endothelial cells lining the blood vessels of the liver. This tumour can range from benign to low-grade malignant and is considered less aggressive than angiosarcoma, another type of liver vascular tumour. Haemangioendotheliomas are part of a spectrum of vascular neoplasms and can present at any age.
Symptoms
The symptoms of hepatic haemangioendothelioma can be nonspecific and may not appear until the tumour reaches a significant size. Symptoms can include:
- Abdominal pain or discomfort
- A palpable mass in the abdomen
- Unintentional weight loss
- Fatigue
- Jaundice (yellowing of the skin and eyes), in some cases
- Ascites (accumulation of fluid in the abdomen)
Disease Aetiology (Causes)
The exact cause of haemangioendothelioma of the liver is unknown. There are no well-established risk factors, and it appears to occur randomly. Some cases have been associated with certain environmental exposures, but these connections are not well defined.
Diagnosis
Diagnosing haemangioendothelioma involves a combination of imaging studies and biopsy. Diagnostic procedures may include:
- Ultrasound, CT scans, and MRI to visualize the liver and identify abnormal growths.
- Angiography to assess the blood supply to the liver and the tumour.
- Biopsy of the liver tissue for histological examination, which is essential for confirming the diagnosis.
Treatment
Treatment for haemangioendothelioma of the liver varies depending on the tumour’s size, number, growth rate, and the patient’s overall health. Options may include:
- Surgical resection, which is preferred if the tumour is localized and the patient’s condition permits surgery.
- Liver transplantation in selected cases, particularly for patients with multiple lesions not amenable to resection.
- Radiotherapy and chemotherapy, which may be considered for unresectable tumours or to reduce symptoms.
- Targeted therapy, including drugs that specifically target the growth of blood vessels (angiogenesis inhibitors), is being explored as a treatment option.
What support can we give for the PHaemangioendothelioma of the Liver?
Haemangioendothelioma of the Liver is a rare cancer, meaning it is not as well-known as other forms of cancer. Without a Ribbon is an Australian organisation that provides support for individuals who suffer from rare cancers. So, we provide a designated platform for Warriors to obtain information specific to their Rare Cancer. We also provide annual opportunities for our Warriors to meet and learn from each other. If you suffer from rare cancer such as Haemangioendothelioma of the Liver, we can help and support you through your journey thanks to the generous donations we receive. Click the link below to sign up and become a Warrior today!
You can help us with your donation:
Without a Ribbon is a charity that works hard to aid those who suffer from rare cancers. You can help our cause in a variety of ways:
